TOKYO -- Japanese health authorities on Thursday approved remdesivir for use against the novel coronavirus, piggybacking on the antiviral drug's U.S. authorization in order to accelerate the process.
Step comes on heels of US authorization last week
Japan approved the use of remdesivir as a treatment for COVID-19 using an expedited process. © Reuters
TOKYO -- Japanese health authorities on Thursday approved remdesivir for use against the novel coronavirus, piggybacking on the antiviral drug's U.S. authorization in order to accelerate the process.